rs770225915
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000191.3(HMGCL):c.121C>T(p.Arg41*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R41R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000191.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151970Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251480Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461550Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727078
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151970Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74198
ClinVar
Submissions by phenotype
Deficiency of hydroxymethylglutaryl-CoA lyase Pathogenic:7
Variant summary: HMGCL c.121C>T (p.Arg41X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251480 control chromosomes. c.121C>T has been reported in the literature without a second allele identified in at-least one individual affected with HMG-CoA Lyase Deficiency (example, Mitchell_1998 cited in Menao_2009). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
A homozygous nonsense variant was identified, NM_000191.2(HMGCL):c.121C>T in exon 2 of 9 of the HMGCL gene. This nonsense variant is predicted to create a change of an arginine to a stop at amino acid position 41 of the protein; NP_000182.2(HMGCL):p.(Arg41*), resulting in the loss of normal protein function through nonsense-mediated decay (NMD). The variant is present in the gnomAD population database at a frequency of 0.0004% (1 heterozygote, 0 homozygotes) and has been previously identified in patients with HMG-CoA lyase deficiency (ClinVar, Mitchell G. et al. (1998)). Other variants predicted to cause NMD have been reported as pathogenic in individuals with HMG-CoA lyase deficiency (ClinVar). Based on information available at the time of curation, this variant has been classified as PATHOGENIC. Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
- -
This sequence change creates a premature translational stop signal (p.Arg41*) in the HMGCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCL are known to be pathogenic (PMID: 9817922, 17692550, 23465862). This variant is present in population databases (rs770225915, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with HMG-CoA lyase deficiency (PMID: 9463337). ClinVar contains an entry for this variant (Variation ID: 553933). For these reasons, this variant has been classified as Pathogenic. -
- -
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at